News on Enzon Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Enzon Pharmaceuticals news from BioPortfolio.com Tue, 09 Feb 2010 23:24:54 GMT en Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Followhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036346&HITNO=0&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036346&THISHREF=http://c.moreover.com/click/here.pl%3fz2536580876%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036346&HITNO=0&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036346&THISHREF=http://c.moreover.com/click/here.pl%3fz2536580876%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Followhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037000&HITNO=1&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037000&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037000&HITNO=1&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037000&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859440%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Followhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036342&HITNO=2&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536580183%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036342&HITNO=2&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536580183%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast tohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037556&HITNO=3&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037556&THISHREF=http://c.moreover.com/click/here.pl%3fz2537140211%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037556&HITNO=3&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037556&THISHREF=http://c.moreover.com/click/here.pl%3fz2537140211%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast tohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036222&HITNO=4&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036222&THISHREF=http://c.moreover.com/click/here.pl%3fz2536535838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036222&HITNO=4&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036222&THISHREF=http://c.moreover.com/click/here.pl%3fz2536535838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Pharma manufacturing news in briefhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028094&HITNO=5&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028094&THISHREF=http://c.moreover.com/click/here.pl%3fz2532575198%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028094&HITNO=5&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028094&THISHREF=http://c.moreover.com/click/here.pl%3fz2532575198%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Enzon Pharmaceuticals: The Trend Continues Down (ENZN) - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020102&HITNO=6&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020102&THISHREF=http://c.moreover.com/click/here.pl%3fz2526602929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020102&HITNO=6&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020102&THISHREF=http://c.moreover.com/click/here.pl%3fz2526602929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Enzon Pharmaceuticals: The Trend Continues Down (ENZN)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019982&HITNO=7&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019982&THISHREF=http://c.moreover.com/click/here.pl%3fz2526550562%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019982&HITNO=7&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019982&THISHREF=http://c.moreover.com/click/here.pl%3fz2526550562%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Form SC 13G ENZON PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023609&HITNO=8&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023609&THISHREF=http://c.moreover.com/click/here.pl%3fz2528278473%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023609&HITNO=8&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023609&THISHREF=http://c.moreover.com/click/here.pl%3fz2528278473%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Enzon Pharmaceuticals: The Trend Continues Down (ENZN)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020259&HITNO=9&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020259&THISHREF=http://c.moreover.com/click/here.pl%3fz2526664755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020259&HITNO=9&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020259&THISHREF=http://c.moreover.com/click/here.pl%3fz2526664755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Enzon Pharmaceuticals: The Trend Continues Down (ENZN)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020089&HITNO=10&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020089&THISHREF=http://c.moreover.com/click/here.pl%3fz2526595207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020089&HITNO=10&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020089&THISHREF=http://c.moreover.com/click/here.pl%3fz2526595207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Enzon Completes Sale of Specialty Pharmaceutical Businesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001865&HITNO=11&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001865&THISHREF=http://c.moreover.com/click/here.pl%3fz2518606119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001865&HITNO=11&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001865&THISHREF=http://c.moreover.com/click/here.pl%3fz2518606119%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Enzon Pharmaceuticals Inc-Therapeutic Competitors - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006443&HITNO=12&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006443&THISHREF=http://c.moreover.com/click/here.pl%3fz2520727017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006443&HITNO=12&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006443&THISHREF=http://c.moreover.com/click/here.pl%3fz2520727017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Enzon selling pharma planthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008747&HITNO=13&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008747&THISHREF=http://c.moreover.com/click/here.pl%3fz2521657133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008747&HITNO=13&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008747&THISHREF=http://c.moreover.com/click/here.pl%3fz2521657133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndy.com: Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008042&HITNO=14&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008042&THISHREF=http://c.moreover.com/click/here.pl%3fz2521396302%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008042&HITNO=14&MSIZE=172&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Enzon%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008042&THISHREF=http://c.moreover.com/click/here.pl%3fz2521396302%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: